We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$411M
AUM Growth
-$86.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$265M 64.62%
15,001,073
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$98.2M 23.93%
2,679,835
ALKS icon
3
Alkermes
ALKS
$8.82B
$17.4M 4.24%
892,400
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$10.7M 2.62%
320,000
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$9.54M 2.32%
400,000
SDS icon
6
ProShares UltraShort S&P500
SDS
$406M
$3.39M 0.83%
4,600
SPXU icon
7
ProShares UltraPro Short S&P 500
SPXU
$436M
$2.73M 0.66%
1,050
SQQQ icon
8
ProShares UltraPro Short QQQ
SQQQ
$2.21B
$2.32M 0.56%
114
CLDX icon
9
Celldex Therapeutics
CLDX
$2.77B
$896K 0.22%
420,846

Similar funds

Meditor Group's Q3 2019 Portfolio in Review

As of Q3 2019, Meditor Group held 9 positions worth $411M, down 17% from $497M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier.

  • Meditor Group's ten largest holdings make up 100% of its $411M portfolio in Q3 2019.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2019.
  • Meditor Group's portfolio value fell 17% quarter-over-quarter to $411M.

Based on Meditor Group's 13F filing for Q3 2019, filed 31 Oct 2019.